GAMELIN ERICK (Chief Development Officer) received a stock award from ACRIVON THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/20/2026ACC: 0000905148-26-002551
Officer· Chief Development Officer
Since Mar 2026
+38.58K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
38.58K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+38.58K
Price / share
—
Trade value
—
% of position
267.8%
5/18/2026
14.41K→52.99K
Total
Net shares
+38.58K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2026 | A · Award | +38.58K | — | — | 267.8% | 14.41K | 52.99K |
| Total | +38.58K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported